SPECTROX Trademark

Trademark Overview

On Friday, September 1, 2023, a trademark application was filed for SPECTROX with the United States Patent and Trademark Office. The USPTO has given the SPECTROX trademark a serial number of 98161875. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 30, 2024. This trademark is owned by SpectraCell Laboratories. The SPECTROX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient
spectrox

General Information

Serial Number98161875
Word MarkSPECTROX
Filing DateFriday, September 1, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, April 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical information services, namely, reporting of consumer authorized clinical testing results directly to the patient

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 1, 2023
Primary Code044
First Use Anywhere DateMonday, September 19, 1994
First Use In Commerce DateMonday, September 19, 1994

Trademark Owner History

Party NameSpectraCell Laboratories
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77072

Trademark Events

Event DateEvent Description
Friday, September 1, 2023NEW APPLICATION ENTERED
Wednesday, November 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024ASSIGNED TO EXAMINER

Related Keywords

spectrox testing clinical results directly patient authorized consumer information services namely